Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...

The stock price of Hims & Hers Health (NYSE: HIMS), a telehealth platform, has risen a solid 14% in a week. Much of this move came after the U.S. FDA asked for more time to confirm the shortage of ...

These mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Hims & Hers' financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Citi notes that the FDA said in a status report filed in a Texas court that it needs more time to determine if Eli Lilly’s (LLY) tirzepatide ...

Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...

To help its customers stay on top of their protein and nutrient intake and simplify access to the critical nutrition support they need, Hims & Hers announced its customers will now be able to have ...